Has Lupin Pharmaceuticals Inc. had other FDA enforcement actions?

Yes. Argus HQ has recorded 4 total FDA actions tied to Lupin Pharmaceuticals Inc.: 0 warning letters, 4 recalls, 0 approval records, and 0 Form 483 inspection citations.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2026-05-27; Argus observed and indexed it on 2026-07-09.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_recall · drug_recall · high

Lupin Pharmaceuticals Inc. — Class II recall: Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Ph…

Name: FDA Recall Record — Lupin Pharmaceuticals Inc.
Creator: Argus HQ
Published: 2026-05-27
License: https://argushq.ai/methodology

Event date: 2026-05-27 00:00:00Z
Observed: 2026-07-09 22:51:39Z
Source ID: D-0541-2026
Payload hash: b477cb94e0da48d7cbf5ab0b…

Summary

Presence of particulate matter: a white thread-like structure in the cartridge Status: Ongoing.

Entities

Lupin Pharmaceuticals Inc.

View source record ↗

Frequently asked questions

Has Lupin Pharmaceuticals Inc. had other FDA enforcement actions?: Yes. Argus HQ has recorded 4 total FDA actions tied to Lupin Pharmaceuticals Inc.: 0 warning letters, 4 recalls, 0 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2026-05-27; Argus observed and indexed it on 2026-07-09.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Lupin Pharmaceuticals Inc. — Class II recall: Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Ph…. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-recall-lupin-pharmaceuticals-inc-d-0541-2026

MLA

"Lupin Pharmaceuticals Inc. — Class II recall: Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Ph…." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-recall-lupin-pharmaceuticals-inc-d-0541-2026.

Chicago

Argus HQ Research. "Lupin Pharmaceuticals Inc. — Class II recall: Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Ph…." Digital Empire Holdings LLC. Accessed August 27, 2026. https://argushq.ai/events/fda-recall-lupin-pharmaceuticals-inc-d-0541-2026.

BibTeX

@misc{argushq_argushq_ai_events_fda_recall_lupin_pharmaceuticals_inc_d_0541_2026_2026,
  title = {Lupin Pharmaceuticals Inc. — Class II recall: Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Ph…},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-recall-lupin-pharmaceuticals-inc-d-0541-2026},
  note = {Accessed: August 27, 2026}
}

Informational only. Not legal, financial, or medical advice.